Next Article in Journal
On the Critical Issues in Temozolomide Research in Glioblastoma: Clinically Relevant Concentrations and MGMT-independent Resistance
Previous Article in Journal
Temozolomide in Glioblastoma Therapy: Role of Apoptosis, Senescence and Autophagy. Comment on Strobel et al., Temozolomide and Other Alkylating Agents in Glioblastoma Therapy. Biomedicines 2019, 7, 69
 
 
Article

Article Versions Notes

Action Date Notes Link
article xml file uploaded 23 November 2019 08:22 CET Original file -
article xml uploaded. 23 November 2019 08:22 CET Update -
article pdf uploaded. 23 November 2019 08:22 CET Version of Record https://0-www-mdpi-com.brum.beds.ac.uk/2227-9059/7/4/91/pdf-vor
article supplementary file uploaded. 23 November 2019 08:22 CET - https://0-www-mdpi-com.brum.beds.ac.uk/2227-9059/7/4/91#supplementary
article html file updated 23 November 2019 08:24 CET Original file -
article xml file uploaded 28 November 2019 04:14 CET Update -
article xml uploaded. 28 November 2019 04:14 CET Update https://0-www-mdpi-com.brum.beds.ac.uk/2227-9059/7/4/91/xml
article pdf uploaded. 28 November 2019 04:14 CET Updated version of record https://0-www-mdpi-com.brum.beds.ac.uk/2227-9059/7/4/91/pdf
article html file updated 28 November 2019 04:16 CET Update -
article html file updated 31 December 2019 12:09 CET Update -
article html file updated 1 January 2020 05:45 CET Update -
article html file updated 14 February 2020 12:24 CET Update -
article html file updated 19 July 2022 23:11 CEST Update https://0-www-mdpi-com.brum.beds.ac.uk/2227-9059/7/4/91/html
Back to TopTop